Fs(2)KetRP13, PenD14 has increased mortality during development | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/PenNLSB-.UASp
Fs(2)KetRP13, PenD14 has increased mortality during development | maternal effect phenotype, enhanceable by PenSNLSB-.UASp/Scer\GAL4VP16.nanos.UTR
Fs(2)KetRP13 has increased mortality during development | maternal effect phenotype, non-enhanceable by PenD14
Fs(2)KetRP13, PenD14 has increased mortality during development | maternal effect phenotype, non-enhanceable by Scer\GAL4VP16.nanos.UTR/PenCASB-.UASp
Fs(2)KetRP13, PenD14 has increased mortality during development | maternal effect phenotype, non-enhanceable by Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp
Fs(2)KetRP13 has increased mortality during development | maternal effect phenotype, non-suppressible by PenD14
Fs(2)KetRP13, PenD14 has increased mortality during development | maternal effect phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/PenCASB-.UASp
Fs(2)KetRP13, PenD14 has increased mortality during development | maternal effect phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp
Fs(2)KetRP13 is a non-enhancer of increased mortality during development | maternal effect phenotype of PenD14
Fs(2)KetRP13 is a non-suppressor of increased mortality during development | maternal effect phenotype of PenD14
Revertant.